ASTA Follows Up with FDA on Saffron Holds and Rejections
ASTA Executive Director Laura Shumow met with U.S. Food and Drug Administration (FDA) officials regarding the increased inspection and detention of saffron shipments for economically motivated adulteration.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
FDA Extends Comment Period for Revised “Appendix 1” Draft Guidance
News & Updates
Industry News
5/29/2024
FDA extended the comment period for the revised Appendix 1: Known or Reasonably Foreseeable Hazards (“Potential Hazards”) of the Hazard Analysis and Risk-Based Preventive Controls for Human Food: Draft Guidance for Industry by 60 days.
ASTA Provides Feedback to GAO on FDA Implementation of FSMA
News & Updates
Industry News
10/15/2024
This is an article from the October 15, 2024, FYI ASTA newsletter.
